Organovo Presents First Preclinical Data on 3D Bioprinted Human Liver Tissues at TERMIS-Americas Meeting
Organovo Holdings, Inc. (NASDAQ:ONVO) («Organovo»), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, is presenting the first data showing survival and sustained functionality of its 3D bioprinted human liver tissue when implanted into animal models.